Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis
Clinical trial NCT05549947 · COMPLETED
Trial details
- NCT number
- NCT05549947
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-08
- Primary completion
- 2023-09-15
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.